|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| 20/07/16 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/07/16 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 08/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 31/12/2004 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 24/08/2016 | |
| Director/Board Member | 58 | 24/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.48% | -6.72% | +44.19% | +156.43% | 1,028B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 611B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 432B | |
| -0.49% | -2.63% | +27.88% | +21.59% | 323B | |
| -0.65% | -3.21% | +26.86% | +43.50% | 277B | |
| -0.43% | -13.33% | +17.59% | +21.00% | 257B | |
| +0.65% | -0.34% | -25.64% | -39.92% | 217B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 192B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 161B | |
| Average | -0.65% | -5.24% | +24.02% | +51.78% | 388.7B | |
| Weighted average by Cap. | -0.52% | -5.52% | +33.45% | +76.86% |
- Stock Market
- Stocks
- Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
